Quest Diagnostics (DGX) Cash from Investing Activities (2009 - 2026)

Quest Diagnostics has disclosed Cash from Investing Activities across 18 years of filings, most recently posting -$134.0 million for Q2 2026.

• In Q2 2026, Cash from Investing Activities fell 8.06% year-over-year to -$134.0 million; the TTM figure through Jun 2026 stood at -$678.0 million (up 71.44% YoY), while the FY2025 annual figure was -$631.0 million, up 75.24% from the prior year.
• Cash from Investing Activities came in at -$134.0 million for Q2 2026 at Quest Diagnostics, up from -$152.0 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$82.0 million in Q2 2022 to a low of -$1.6 billion in Q3 2024.
• Average Cash from Investing Activities over 5 years is -$281.6 million, with a median of -$163.5 million recorded in 2022.
• Year-over-year, Cash from Investing Activities sank 1426.17% in 2024 and soared 87.69% in 2025.
• Over 5 years, Cash from Investing Activities stood at -$174.0 million in 2022, then jumped by 34.48% to -$114.0 million in 2023, then tumbled by 340.35% to -$502.0 million in 2024, then surged by 61.95% to -$191.0 million in 2025, then grew by 29.84% to -$134.0 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$134.0 million in Q2 2026, -$152.0 million in Q1 2026, and -$191.0 million in Q4 2025.